SCHEMBL26570926

SCHEMBL26570926

FC(F)(F)c1ccc(-c2ccc(-c3ccc4cc(-c5ccc(-c6ccc(C7CC7)cc6)cc5)cnc4c3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.43
P2RY14 Q15391 11/20 0.43
DRD5 P21918 4/20 0.43
TMEM97 Q5BJF2 4/20 0.43
DRD3 P35462 3/20 0.43
ADRB3 P13945 3/20 0.43
DRD1 P21728 3/20 0.43
SIGMAR1 Q99720 3/20 0.43
HTR1A P08908 2/20 0.43
SLC6A2 P23975 2/20 0.43
AGTR1 P30556 2/20 0.43
SLC6A3 Q01959 2/20 0.43
ADRA2A P08913 2/20 0.43
ADRA2C P18825 2/20 0.43
ADRA1B P35368 2/20 0.43
PDE2A O00408 1/20 0.43
PDE5A O76074 1/20 0.43
EGFR P00533 1/20 0.43
INSR P06213 1/20 0.43
ADRA2B P18089 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26549175 0.87 ESR2 (0.53) EGFRESR2GAKPDGFRBPDGFRA
SCHEMBL26549449 0.87 ESR2 (0.53) EGFRESR2GAKPDGFRBPDGFRA
SCHEMBL26570916 0.85 PDGFRB (0.49) ESR2GAKPDGFRBPDGFRA
SCHEMBL26549185 0.85 GAK (0.48) EGFRESR2GAKPDGFRBPDGFRA
SCHEMBL26549457 0.85 GAK (0.48) EGFRESR2GAKPDGFRBPDGFRA
SCHEMBL26550422 0.85 GAK (0.48) EGFRESR2GAKPDGFRBPDGFRA
SCHEMBL26549177 0.85 GAK (0.48) EGFRESR2GAKPDGFRBPDGFRA
SCHEMBL26549359 0.82 PDGFRB (0.59) EGFRESR2GAKPDGFRBPDGFRA
SCHEMBL26549166 0.82 PDGFRB (0.51) ESR2GAKPDGFRBPDGFRACA12
SCHEMBL26558890 0.82 ESR2 (0.50) ESR2GAKPDGFRBPDGFRACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 HTR2C 4038/4885P2RY14 2670/4885DRD5 3922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.